Skip to main
KMTS
KMTS logo

KMTS Market Capitalization Overview

Market Cap: $1.17B as of Oct 13, 2025

$1.17B
Past Month+$40.78M (3.64%)
As of Oct 13, 2025, KMTS has a market capitalization of $1.17B. Over the past 30 days, its market cap has increased by 50.11%, while in the last 12 months, it has increased by .

Market capitalization represents the total value of Kestra Medical Technologies Inc as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

KMTS Market Cap Formula = Stock Price * Shares Outstanding

The market cap of KMTS helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

KMTS Market Cap History

DateMarket CapChange
Oct 1, 2025$1.25B+50.11%
Sep 2, 2025$827.75M+4.81%
Aug 1, 2025$789.75M-2.90%
Jul 1, 2025$813.37M-23.40%
Jun 2, 2025$1.07B-9.93%
May 1, 2025$1.18B-3.17%
Apr 1, 2025$1.22B+67,590.04%
Mar 5, 2025$1.80M

KMTS End of Year Market Cap History

DateMarket CapChange
2025$1.17B

FAQs About Kestra Medical Technologies Inc (KMTS) Market Cap

As of Oct 13, 2025, the market capitalization of KMTS is $1.17B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Kestra Medical Technologies Inc’s market capitalization has increased by 3.64%, changing from $1.13B to $1.17B as of Oct 13, 2025.

In the last 3 months, Kestra Medical Technologies Inc’s market capitalization has increased by —, changing from – to – as of –.

In the year –, Kestra Medical Technologies Inc’s market capitalization increased from – in January to – in December, reflecting a — change.

Kestra Medical Technologies Inc (KMTS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.